{"id":25665,"date":"2022-06-16T10:20:00","date_gmt":"2022-06-16T14:20:00","guid":{"rendered":"https:\/\/www.thinkresearch.com\/ca\/?p=25665"},"modified":"2022-06-16T10:46:29","modified_gmt":"2022-06-16T14:46:29","slug":"biopharma-services-inc-achieves-another-successful-fda-inspection-result","status":"publish","type":"post","link":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/","title":{"rendered":"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result"},"content":{"rendered":"\n<p><em>The subsidiary has seen stellar audit performance results of zero Form 483s since 2009<\/em><\/p>\n\n\n\n<p><strong>TORONTO, ON &#8211; June 16, 2022<\/strong> &#8211; Think Research Corporation (TSXV:THNK) (OTCQB: THKKF) (\u201c<strong>Think<\/strong>\u201d or the \u201c<strong>Company<\/strong>\u201d), a company focused on transforming healthcare through digital health software solutions, is pleased to announce its subsidiary, <a href=\"https:\/\/www.biopharmaservices.com\/\">BioPharma Services Inc<\/a>., (\u201c<strong>BioPharma<\/strong>\u201d) has continued its record of audit achievement following the successful completion of an audit by the United States Food and Drug Administration (the \u201c<strong>FDA<\/strong>\u201d) of BioPharma\u2019s Toronto clinical facility for compliance with Good Clinical Practice (\u201c<strong>GCP<\/strong>\u201d) regulations.<\/p>\n\n\n\n<p>The FDA Inspector, observed by Health Canada, reviewed two studies during the week of May 9, 2022, resulting in no critical findings and the issuance of zero Form 483 observations.<sup>[1]<\/sup>&nbsp; The fact that the inspection concluded 1 day earlier than scheduled with no issuance of a Form 483 speaks volumes to the quality and compliance maintained by BioPharma.&nbsp; The successful results build on BioPharma\u2019s record of excellence with respect to regulatory audits conducted by the FDA. Since 2009, the FDA has conducted 13 GCP inspections of BioPharma facilities in Canada and the US without a single Form 483 observation being issued, signifying BioPharma\u2019s unwavering compliance and conformance to applicable GCP regulations.<\/p>\n\n\n\n<p>BioPharma is leading the digitalization of the clinical research industry with its award-winning facilities in Toronto, Canada and St. Louis, USA. Earlier this year, BioPharma announced the launch of its clinical trial <a href=\"https:\/\/www.thinkresearch.com\/ca\/2022\/03\/29\/think-research-launches-electronic-data-capture-system-for-its-clinical-research-phase-1-business-bio-pharma-services-inc\/\">Electronic Data Capture (\u201c<\/a><a href=\"https:\/\/www.thinkresearch.com\/ca\/2022\/03\/29\/think-research-launches-electronic-data-capture-system-for-its-clinical-research-phase-1-business-bio-pharma-services-inc\/\"><strong>EDC<\/strong><\/a><a href=\"https:\/\/www.thinkresearch.com\/ca\/2022\/03\/29\/think-research-launches-electronic-data-capture-system-for-its-clinical-research-phase-1-business-bio-pharma-services-inc\/\">\u201d)<\/a> platform, which expedites Phase 1 clinical trial timelines, improves access to data for sponsors, and enables clients to shorten their drug development timelines to get therapeutics to the market faster.<\/p>\n\n\n\n<p><strong>Jo Ann Di Sensi, VP Global Quality and Privacy Officer at BioPharma<\/strong> said, \u201cThis latest inspection exemplifies BioPharma\u2019s consistent focus on quality throughout the clinical trial process. With over a decade of successful inspections by the FDA, as well as other leading regulatory bodies such as Health Canada, Standards Council of Canada, EMA (ANSM &amp; DKMA), UK MHRA and ANVISA, BioPharma continues to be a partner of choice for innovative Phase 1 development programs.\u201d<\/p>\n\n\n\n<p><strong>Renzo DiCarlo, President of Clinical Research at BioPharma<\/strong> said, \u201cThis latest FDA inspection truly showcases BioPharma\u2019s commitment to provide robust, valuable data to our clients. With an outstanding audit record spanning over 13 years, I\u2019m so very proud of our Think Research Family.\u201d<\/p>\n\n\n\n<p><strong>Sachin Aggarwal, CEO at Think<\/strong> said, \u201cThe positive results of the audit by the FDA are a testament to the hard work and dedication of each employee at BioPharma. I commend the team for their commitment to providing a level of quality and excellence clients can depend on.\u201d<\/p>\n\n\n\n<p><strong>About Think Research Corporation<\/strong><\/p>\n\n\n\n<p>Think Research is an industry leader in delivering knowledge-based digital healthcare software solutions. The Company\u2019s focused mission is to organize the world\u2019s health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes. For over a decade, Think\u2019s cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care \u2013 including primary physician care, acute care hospitals and surgical suites as well as community and seniors\u2019 care. Think is proud to serve as a trusted health system partner to a rapidly growing, global client base that spans five continents across more than 13,000 healthcare facilities, with a clinical audience of over 300,000 doctors, nurses and pharmacists. Visit: <a href=\"http:\/\/www.thinkresearch.com\">www.thinkresearch.com<\/a><\/p>\n\n\n\n<p><strong>About BioPharma Services Inc.<\/strong><\/p>\n\n\n\n<p>BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase 1\/2a and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma Services has clinical research facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma\u2019s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing.<\/p>\n\n\n\n<p>For more information about BioPharma Services, contact Ms. Anna Taylor, EVP of Commercial Operations at <a href=\"mailto:ataylor@biopharmaservices.com\">ataylor@biopharmaservices.com<\/a><\/p>\n\n\n\n<p><strong><em>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/em><\/strong><\/p>\n\n\n\n<p><strong>For more information:<\/strong><a href=\"https:\/\/www.thinkresearch.com\/ca\/investors\/\"> <\/a><a href=\"https:\/\/www.thinkresearch.com\/ca\/investors\/\">https:\/\/www.thinkresearch.com\/ca\/investors\/<\/a><\/p>\n\n\n\n<p><strong>For further information:<\/strong> Mark Sakamoto, EVP, Think Research, Direct: 416.388.7119, <a href=\"mailto:mark.sakamoto@thinkresearch.com\">mark.sakamoto@thinkresearch.com<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n\n<p class=\"has-small-font-size\"><sup>[1]<\/sup> An FDA Form 483 is issued at the conclusion of an inspection when an Inspector(s) has(have) observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic (FD&amp;C) Act and related Acts. Observations are made when in the Inspector\u2019s judgment, conditions or practices observed would indicate that any food, drug, device, or cosmetic has been found deficient e.g., inadequate subject protection, inadequate accountability for the investigational product, failure to conduct or supervise the study in accordance with the relevant protocol(s).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON &#8211; June 16, 2022 &#8211; Think Research Corporation (TSXV:THNK) (OTCQB: THKKF) (\u201cThink\u201d or the \u201cCompany\u201d), a company focused on transforming healthcare through digital health software solutions, is pleased to announce its subsidiary, BioPharma Services Inc., (\u201cBioPharma\u201d) has continued its [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":25600,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[28],"tags":[489],"class_list":["post-25665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-press-releases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result - Think Research Canada<\/title>\n<meta name=\"description\" content=\"The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON - June 16, 2022 - Think Research Corporation\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result - Think Research Canada\" \/>\n<meta property=\"og:description\" content=\"The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON - June 16, 2022 - Think Research Corporation\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\" \/>\n<meta property=\"og:site_name\" content=\"Think Research Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TRChealth\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-16T14:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-16T14:46:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png\" \/>\n\t<meta property=\"og:image:width\" content=\"576\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Think Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@trchealth\" \/>\n<meta name=\"twitter:site\" content=\"@trchealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Think Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\"},\"author\":{\"name\":\"Think Research\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/person\/ef6ba5b79403636ee5e4a10045973d61\"},\"headline\":\"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result\",\"datePublished\":\"2022-06-16T14:20:00+00:00\",\"dateModified\":\"2022-06-16T14:46:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\"},\"wordCount\":827,\"publisher\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png\",\"keywords\":[\"press releases\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\",\"url\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\",\"name\":\"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result - Think Research Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png\",\"datePublished\":\"2022-06-16T14:20:00+00:00\",\"dateModified\":\"2022-06-16T14:46:29+00:00\",\"description\":\"The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON - June 16, 2022 - Think Research Corporation\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage\",\"url\":\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png\",\"contentUrl\":\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png\",\"width\":943,\"height\":545,\"caption\":\"Think Research and BioPharma logos\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thinkresearch.com\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.thinkresearch.com\/ca\/category\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#website\",\"url\":\"https:\/\/www.thinkresearch.com\/ca\/\",\"name\":\"Think Research Canada\",\"description\":\"Rethinking the future of health care\",\"publisher\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thinkresearch.com\/ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#organization\",\"name\":\"Think Research\",\"url\":\"https:\/\/www.thinkresearch.com\/ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2020\/10\/LogoforBlog-01.png\",\"contentUrl\":\"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2020\/10\/LogoforBlog-01.png\",\"width\":1025,\"height\":684,\"caption\":\"Think Research\"},\"image\":{\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/TRChealth\/\",\"https:\/\/x.com\/trchealth\",\"https:\/\/www.instagram.com\/thinkresearch\/\",\"https:\/\/www.linkedin.com\/company\/thinkresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/person\/ef6ba5b79403636ee5e4a10045973d61\",\"name\":\"Think Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/065648787c39d2e4e4eed71f3f6041ca3009f2d472da140c31892ae2567cb581?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/065648787c39d2e4e4eed71f3f6041ca3009f2d472da140c31892ae2567cb581?s=96&d=mm&r=g\",\"caption\":\"Think Research\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result - Think Research Canada","description":"The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON - June 16, 2022 - Think Research Corporation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/","og_locale":"en_US","og_type":"article","og_title":"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result - Think Research Canada","og_description":"The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON - June 16, 2022 - Think Research Corporation","og_url":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/","og_site_name":"Think Research Canada","article_publisher":"https:\/\/www.facebook.com\/TRChealth\/","article_published_time":"2022-06-16T14:20:00+00:00","article_modified_time":"2022-06-16T14:46:29+00:00","og_image":[{"width":576,"height":576,"url":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png","type":"image\/png"}],"author":"Think Research","twitter_card":"summary_large_image","twitter_creator":"@trchealth","twitter_site":"@trchealth","twitter_misc":{"Written by":"Think Research","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#article","isPartOf":{"@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/"},"author":{"name":"Think Research","@id":"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/person\/ef6ba5b79403636ee5e4a10045973d61"},"headline":"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result","datePublished":"2022-06-16T14:20:00+00:00","dateModified":"2022-06-16T14:46:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/"},"wordCount":827,"publisher":{"@id":"https:\/\/www.thinkresearch.com\/ca\/#organization"},"image":{"@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png","keywords":["press releases"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/","url":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/","name":"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result - Think Research Canada","isPartOf":{"@id":"https:\/\/www.thinkresearch.com\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage"},"image":{"@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png","datePublished":"2022-06-16T14:20:00+00:00","dateModified":"2022-06-16T14:46:29+00:00","description":"The subsidiary has seen stellar audit performance results of zero Form 483s since 2009 TORONTO, ON - June 16, 2022 - Think Research Corporation","breadcrumb":{"@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#primaryimage","url":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png","contentUrl":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2022\/06\/Think_BioPharma.png","width":943,"height":545,"caption":"Think Research and BioPharma logos"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thinkresearch.com\/ca\/2022\/06\/16\/biopharma-services-inc-achieves-another-successful-fda-inspection-result\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thinkresearch.com\/ca\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.thinkresearch.com\/ca\/category\/news\/"},{"@type":"ListItem","position":3,"name":"BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result"}]},{"@type":"WebSite","@id":"https:\/\/www.thinkresearch.com\/ca\/#website","url":"https:\/\/www.thinkresearch.com\/ca\/","name":"Think Research Canada","description":"Rethinking the future of health care","publisher":{"@id":"https:\/\/www.thinkresearch.com\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thinkresearch.com\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.thinkresearch.com\/ca\/#organization","name":"Think Research","url":"https:\/\/www.thinkresearch.com\/ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2020\/10\/LogoforBlog-01.png","contentUrl":"https:\/\/www.thinkresearch.com\/ca\/wp-content\/uploads\/sites\/6\/2020\/10\/LogoforBlog-01.png","width":1025,"height":684,"caption":"Think Research"},"image":{"@id":"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/TRChealth\/","https:\/\/x.com\/trchealth","https:\/\/www.instagram.com\/thinkresearch\/","https:\/\/www.linkedin.com\/company\/thinkresearch"]},{"@type":"Person","@id":"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/person\/ef6ba5b79403636ee5e4a10045973d61","name":"Think Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thinkresearch.com\/ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/065648787c39d2e4e4eed71f3f6041ca3009f2d472da140c31892ae2567cb581?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/065648787c39d2e4e4eed71f3f6041ca3009f2d472da140c31892ae2567cb581?s=96&d=mm&r=g","caption":"Think Research"}}]}},"_links":{"self":[{"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/posts\/25665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/comments?post=25665"}],"version-history":[{"count":0,"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/posts\/25665\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/media\/25600"}],"wp:attachment":[{"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/media?parent=25665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/categories?post=25665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thinkresearch.com\/ca\/wp-json\/wp\/v2\/tags?post=25665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}